KEAP1 and lung cancer: For example, co-mutation of KEAP1/STK11 was more common in patients with KRASG13-mutated lung cancer than in patients with KRASG12D-mutated lung cancer, and co-mutation of KEAP1/STK11 with KRASG13 was associated with poor prognosis and treatment resistance28.